본문 바로가기
KERD
논문KCI 등재

재발성 요로감염에 대한 예방적 항생제 요법

Antimicrobial Prophylaxis for Recurrent Urinary Tract Infection

조대연|박민구
대한요로생식기감염학회|2014.04|Urogenital Tract Infection|제9권 제1호|pp. 1-8

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

AntibioticsAntibiotic prophylaxisRecurrenceUrinary tract infections
주제분류비뇨기과학

초록

Recurrent uncomplicated urinary tract infection (UTI) is a common problem in women, causing considerable morbidity and expense, and is a management burden for clinicians. In management of recurrent UTI, non-antimicrobial approaches to prevention of UTI, such as behavioral modifications should first be tried as a way of minimizing antimicrobial exposure, however, antimicrobial treatment of prophylaxis may be necessary in those who continue to have recurrences. Continuous antimicrobial prophylaxis, post-coital prophylaxis with low dose antimicrobials, and intermittent self-treatment with antimicrobials have all been shown to be effective in prevention of recurrent uncomplicated UTIs. The decision regarding which approach to use for prophylaxis depends on the frequency and pattern of recurrence and the patient’s preference to commit to a specific method. The risk of adverse events and the plan for pregnancy should be considered before starting any regimen of antimicrobial prophylaxis. The susceptibility of the organisms causing the previous UTIs and history of the patient’s drug allergies should be considered before selection of antimicrobials. Before initiation of any prophylaxis regimen, eradication of a previous UTI should be confirmed by a negative urine culture. Continuous antimicrobial prophylaxis is usually used for long periods, thus likely contributing to the widespread problem of antimicrobial resistance. Post-coital prophylaxis and self-treatment approach result in less antimicrobial use, but should be used in the appropriate settings.

Abstract

Recurrent uncomplicated urinary tract infection (UTI) is a common problem in women, causing considerable morbidity and expense, and is a management burden for clinicians. In management of recurrent UTI, non-antimicrobial approaches to prevention of UTI, such as behavioral modifications should first be tried as a way of minimizing antimicrobial exposure, however, antimicrobial treatment of prophylaxis may be necessary in those who continue to have recurrences. Continuous antimicrobial prophylaxis, post-coital prophylaxis with low dose antimicrobials, and intermittent self-treatment with antimicrobials have all been shown to be effective in prevention of recurrent uncomplicated UTIs. The decision regarding which approach to use for prophylaxis depends on the frequency and pattern of recurrence and the patient’s preference to commit to a specific method. The risk of adverse events and the plan for pregnancy should be considered before starting any regimen of antimicrobial prophylaxis. The susceptibility of the organisms causing the previous UTIs and history of the patient’s drug allergies should be considered before selection of antimicrobials. Before initiation of any prophylaxis regimen, eradication of a previous UTI should be confirmed by a negative urine culture. Continuous antimicrobial prophylaxis is usually used for long periods, thus likely contributing to the widespread problem of antimicrobial resistance. Post-coital prophylaxis and self-treatment approach result in less antimicrobial use, but should be used in the appropriate settings.

참고문헌 (56)

  1. Foxman B, "Recurring urinary tract infection: incidence and risk factors", Am J Public Health, 80, pp.331~333 (1990)
  2. Foxman B, "Risk factors for second urinary tract infection among college women", Am J Epidemiol, 151, pp.1194~1205 (2000)
  3. Ikäheimo R, "Recurrence of urinary tract infection in a primary care setting : analysis of a 1-year follow-up of 179women", Clin Infect Dis, 22, pp.91~99 (1996)
  4. Kim ME, "Recurrent cystitis", Korean J Urogenit Tract Infect Inflamm, 5, pp.134~142 (2010)
  5. Pfau A, "Recurrent urinary tract infections in premenopausal women : prophylaxis based on an understanding of the pathogenesis", J Urol, 129, pp.1153~1157 (1983)
  6. Scholes D, "Risk factors for recurrent urinary tract infection in young women", J Infect Dis, 182, pp.1177~1182 (2000)
  7. Scholes D, "Family history and risk of recurrent cystitis and pyelonephritis in women", J Urol, 184, pp.564~569 (2010)
  8. Raz R, "Recurrent urinary tract infections in postmenopausal women", Clin Infect Dis, 30, pp.152~156 (2000)
  9. Lichtenberger P, "Antimicrobial prophylaxis in women with recurrent urinary tract infections", Int J Antimicrob Agents, 38, pp.36~41 (2011)
  10. Stamm WE, "Estrogens and urinary-tract infection", J Infect Dis, 195, pp.623~624 (2007)
  11. Mulvey MA, "Bad bugs and beleaguered bladders : interplay between uropathogenic Escherichia coli and innate host defenses", Proc Natl Acad Sci U S A, 97, pp.8829~8835 (2000)
  12. Rosen DA, "Detection of intracellular bacterial communities in human urinary tract infection", PLoS Med, 4, pp.329~ (2007)
  13. Cardozo L, "A systematic review of estrogens for recurrent urinary tract infections : third report of the hormones and urogenital therapy(HUT)committee", Int Urogynecol J Pelvic Floor Dysfunct, 12, pp.15~20 (2001)
  14. Perrotta C, "Oestrogens for preventing recurrent urinary tract infection in postmenopausal women", Cochrane Database Syst Rev, 2, pp.005131~ (2008)
  15. Albert X, "Antibiotics for preventing recurrent urinary tract infection in non-pregnant women", Cochrane Database Syst Rev, 3, pp.CD001209~ (2004)
  16. Rudenko N, "Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study", Arzneimittelforschung, 55, pp.420~427 (2005)
  17. Nicolle LE, "Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection", J Infect Dis, 157, pp.1239~1242 (1988)
  18. Brumfitt W, "Efficacy and safety profile of long-term nitrofurantoin in urinary infections : 18 years'experience", J Antimicrob Chemother, 42, pp.363~371 (1998)
  19. Yoon H, "Guidelines on the management of acute uncomplicated cystitis and recurrent urinary tract infections in women", Korean J Urogenit Tract Infect Inflamm, 3, pp.264~275 (2008)
  20. Kraft JK, "The natural history of symptomatic recurrent bacteriuria in women", Medicine(Baltimore), 56, pp.55~60 (1977)
  21. Stamm WE, "Natural history of recurrent urinary tract infections in women", Rev Infect Dis, 13, pp.77~84 (1991)
  22. Nicolle LE, "Recurrent urinary tract infection in adult women : diagnosis and treatment", Infect Dis Clin North Am, 1, pp.793~806 (1987)
  23. Harding GK, "Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women", Rev Infect Dis, 4, pp.438~443 (1982)
  24. Chew LD, "Recurrent cystitis in nonpregnant women", West J Med, 170, pp.274~277 (1999)
  25. Epp A, "Recurrent urinary tract infection", J Obstet Gynaecol Can, 32, pp.1082~1101 (2010)
  26. Pfau A, "Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin", J Urol, 142, pp.1276~1278 (1989)
  27. Pfau A, "Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women", J Urol, 152, pp.136~138 (1994)
  28. Pfau A, "Effective prophylaxis for recurrent urinary tract infections during pregnancy", Clin Infect Dis, 14, pp.810~814 (1992)
  29. Nicolle LE, "Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women", Antimicrob Agents Chemother, 33, pp.1032~1035 (1989)
  30. Stapleton A, "Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial", JAMA, 264, pp.703~706 (1990)
  31. Melekos MD, "Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women", J Urol, 157, pp.935~939 (1997)
  32. Wong ES, "Management of recurrent urinary tract infections with patient-administered single-dose therapy", Ann Intern Med, 102, pp.302~307 (1985)
  33. Schaeffer AJ, "Efficacy and safety of self-start therapy in women with recurrent urinary tract infections", J Urol, 161, pp.207~211 (1999)
  34. Mazzei T, "Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections", Int J Antimicrob Agents, 28(Suppl 1), pp.S35~S41 (2006)
  35. Gupta K, "Antimicrobial resistance among uropathogens that cause communityacquired urinary tract infections in women : a nationwide analysis", Clin Infect Dis, 33, pp.89~94 (2001)
  36. Sahm DF, "Multidrug-resistant urinary tract isolates of Escherichia coli : prevalence and patient demographics in the United States in 2000", Antimicrob Agents Chemother, 45, pp.1402~1406 (2001)
  37. Fadda G, "Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey : possible impact on guidelines", J Chemother, 17, pp.251~257 (2005)
  38. Owens RC Jr, "Torsades de pointes associated with fluoroquinolones", Pharmacotherapy, 22, pp.663~668 (2002)
  39. Sode J, "Use of fluroquinolone and risk of Achilles tendon rupture : a population-based cohort study", Eur J Clin Pharmacol, 63, pp.499~503 (2007)
  40. van der Linden PD, "Fluoroquinolones and risk of Achilles tendon disorders : case-control study", BMJ, 324, pp.1306~1307 (2002)
  41. Corrao G, "Evidence of tendinitis provoked by fluoroquinolone treatment : a case-control study", Drug Saf, 29, pp.889~896 (2006)
  42. Giamarellou H, "Pharmacokinetics of three newer quinolones in pregnant and lactating women", Am J Med, 87, pp.49~51S (1989)
  43. Hooton TM, "Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women", JAMA, 273, pp.41~45 (1995)
  44. Brumfitt W, "A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection", Infection, 23, pp.98~102 (1995)
  45. Gower PE, "The use of small doses of cephalexin (125 mg) in the management of recurrent urinary tract infection in women", J Antimicrob Chemother, 1(3 Suppl), pp.93~98 (1975)
  46. Kahlmeter G, "Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study", Int J Antimicrob Agents, 22(Suppl 2), pp.49~52 (2003)
  47. Falagas ME, "Fosfomycin : use beyond urinary tract and gastrointestinal infections", Clin Infect Dis, 46, pp.1069~1077 (2008)
  48. Patel SS, "A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections", Drugs, 53, pp.637~656 (1997)
  49. Schito GC, "The ARESC study : an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections", Int J Antimicrob Agents, 34, pp.407~413 (2009)
  50. Hayashi K, "Other antibiotics", Clin Orthop Relat Res, pp.109~113 (1984)
  51. Arca P, "Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey", J Antimicrob Chemother, 40, pp.393~399 (1997)
  52. Alós JI, "Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections", Rev Esp Quimioter, 20, pp.211~215 (2007)
  53. Kahlmeter G, "Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections", J Antimicrob Chemother, 52, pp.128~131 (2003)
  54. Nicolle LE, "Prophylaxis: recurrent urinary tract infection in women", Infection, 20(Suppl 3), pp.S203~S205 (1992)
  55. Barbut F, "Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea", J Clin Microbiol, 38, pp.2386~2388 (2000)
  56. Blossom DB, "The challenges posed by reemerging Clostridium difficile infection", Clin Infect Dis, 45, pp.222~227 (2007)

관련 논문AI추천

여성의 재발성 요로감염 예방김백남대한감염학회 · Infection and Chemotherapy2012 · 제44권 제5호재발성 요로감염에 대한 비항생제 예방요법김기호대한요로생식기감염학회 · Urogenital Tract Infection2014 · 제9권 제1호2017 Guidelines of The Korean Association of Urogenital Tract Infection and Inflammation: Recurrent Urinary Tract Infection정홍, 최훈, 김기호, 김재헌, 나용길, 이선주, 이승주, 정재민, 정재흥, 조용현, 최현섭대한요로생식기감염학회 · Urogenital Tract Infection2017 · 제12권 제1호Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections강철인, 김백남, 김지은, 민승기, 박대원, 여정균, 위성헌, 이승주, 이희영, 하유신대한감염학회 · Infection and Chemotherapy2018 · 제50권 제1호요로 감염 임상진료지침 권고안: 무증상 세균뇨, 단순 요로감염, 복잡성 요로감염, 세균성 전립선염대한감염학회, 대한화학요법학회, 대한임상미생물학회, 대한요로생식기감염학회대한감염학회 · Infection and Chemotherapy2011 · 제43권 제1호National Trends of Antimicrobial Resistance in Uncomplicated Cystitis이승주, 최현섭대한요로생식기감염학회 · Urogenital Tract Infection2016 · 제11권 제1호

이 간행물의 다른 논문 (10건)

재발성 요로감염에 대한 비항생제 예방요법김기호pp. 9-13전립선수술에 대한 예방적 항생제요법정승일pp. 14-20만성 세균성 전립선염박흥재pp. 21-26Modulation of Antimicrobial Peptide Human β-defensin-3 by Toll-like Receptor Ligands in Vaginal Epithelial Cells명순철, 김해종, 문영태, 장인호, 김경도, 한준현, 이소연pp. 27-33방광요관역류 소아에서 내시경 수술 후 요로감염의 빈도 및 위험인자구자윤, 박부경, 이상돈pp. 34-38
원문 보기